Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Learn More ›

Pharma

How do I predict treatment outcomes to develop targeted therapies?

Tapestri enables precision disease profiling and therapeutic characterization at the single-cell level to empower next-generation therapies.

Learn More

CGT

How can we avoid late stage cell & gene therapy failures?

Trade the assumptions and inefficiencies that come from conventional analytical workflows for the clarity of Tapestri. Measure multiple attributes within one assay at single-cell resolution to gain a definitive understanding of your therapeutic during early development.

Learn More

Solid Tumor

What if I could predict which clone will cause a tumor to metastasize?

Ask the questions you could never ask before with the new Tapestri Solution for Solid Tumor Research.

Learn More

Pharma

What are the clonal drivers of relapse and therapeutic resistance?

Get deeper insight into your clinical samples with Pharma Assay Development (PAD) services.

Explore PAD Services

Oncology Brand

What if you could read the mind of a cancer cell?

Gain the single-cell insights needed to answer cancer’s toughest questions, reveal its mechanisms of resistance and relapse, and develop effective treatment options.

Learn More

LATEST

Memorial Sloan Kettering researchers present predictive findings from first use of Mission Bio’s scMRD assay for AML

CAPABILITIES

DNA Is Our Foundation

Providing cancer researchers with the only single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.

Single-cell Genomics (DNA)

SNV

Leverage single-cell technology to detect rare clonal populations and identify co-occurrence and zygosity.

LEARN MORE

SNV + CNV

Characterize genetic and copy number aberrations using a single comprehensive platform.

LEARN MORE

Single-cell Multi-omics (DNA + Protein)

DNA + Protein

Gain a true multi-omics picture from genotype to phenotype.

LEARN MORE

APPLICATIONS

Hematologic Malignancies

Clonal evolution impacts response, resistance, relapse, and residual disease.

LEARN MORE

Solid Tumors

Profiling enables high resolution of genomic diversity in a variety of tumor types.

LEARN MORE

Genome Editing

Single-cell technology provides quality control, ensuring the appropriate edits are incorporated.

LEARN MORE

PRODUCTS

The Tapestri Platform

The first and only single-cell technology developed to reveal biomarkers that help stratify patients, signal resistance, and predict relapse. Tapestri’s powerful multi-omics capability — connecting genotype and phenotype — opens the door to a deeper understanding and improved treatment of cancer.